Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0503214 on October 13, 2003

Published online before print October 13, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0503214v1
75/3/408    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benjamim, C. F.
Right arrow Articles by Kunkel, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjamim, C. F.
Right arrow Articles by Kunkel, S. L.
(Journal of Leukocyte Biology. 2004;75:408-412.)
© 2004 by Society for Leukocyte Biology

The chronic consequences of severe sepsis

Claudia F. Benjamim, Cory M. Hogaboam and Steven L. Kunkel1

Department of Pathology, University of Michigan, Ann Arbor

1 Correspondence: Department of Pathology, Medical Science I, University of Michigan, 1301 Catherine Street, Ann Arbor, MI 48109-0602. E-mail: slkunkel{at}umich.edu

The early events of severe sepsis set in motion a cascade of events that significantly contributes to the morbidity and mortality observed during the first few days of this syndrome. Although sepsis is a deadly, acute disease, survivors also suffer long-term consequences. Clinical data underscore subsequent high mortality rates associated with patients who are long-term survivors of the acute septic episode. Within 1 year of surviving severe sepsis, there is a 26% predicted mortality rate, and many patients succumb to lung complications. In this review, we focus on the cellular and molecular mechanisms that dictate the longer-term sequela of sepsis and related lung injury. We have established a murine model of experimental sepsis [cecal ligation and puncture (CLP)], which results in an approximate 60% survival rate. Our studies have demonstrated that these survivors are susceptible to a fungal infection with 100% mortality when challenged 3 days or 15 days post-recovery from the initial CLP. This increased mortality correlates with changes in cytokines and Toll-like receptor expression and alterations in lung leukocyte populations. We hypothesize that the lung becomes predisposed to nosocomial infections for extended periods of time after severe sepsis via mechanisms that include alterations in inflammatory cytokines and an increase in immunomodulatory chemokines, such as monocyte chemoattractant protein-1 and C10. These mediators may alter the innate-immune response by affecting dendritic cells and macrophages, which could provide a mechanism for the immunosuppression observed following sepsis.

Key Words: innate immunity • acquired immunity • long-term • lung • chemokines • Toll-like receptors




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H. Wen, M. A. Schaller, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes
J. Leukoc. Biol., March 1, 2008; 83(3): 439 - 446.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Wen, Y. Dou, C. M. Hogaboam, and S. L. Kunkel
Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response
Blood, February 15, 2008; 111(4): 1797 - 1804.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Chen, M. J. Cowan, J. D. Hasday, S. N. Vogel, and A. E. Medvedev
Tobacco Smoking Inhibits Expression of Proinflammatory Cytokines and Activation of IL-1R-Associated Kinase, p38, and NF-{kappa}B in Alveolar Macrophages Stimulated with TLR2 and TLR4 Agonists
J. Immunol., November 1, 2007; 179(9): 6097 - 6106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Coelho, M. A. Schaller, C. F. Benjamim, A. Z. Orlofsky, C. M. Hogaboam, and S. L. Kunkel
The Chemokine CCL6 Promotes Innate Immunity via Immune Cell Activation and Recruitment
J. Immunol., October 15, 2007; 179(8): 5474 - 5482.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. A. Markel, P. R. Crisostomo, M. Wang, C. M. Herring, K. K. Meldrum, K. D. Lillemoe, and D. R. Meldrum
The struggle for iron: gastrointestinal microbes modulate the host immune response during infection
J. Leukoc. Biol., February 1, 2007; 81(2): 393 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko
Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis
J. Immunol., May 1, 2006; 176(9): 5616 - 5626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Faulkner, A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan
The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
J. Immunol., November 15, 2005; 175(10): 6870 - 6877.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Haley, C. Parent, X. Cui, A. Kalil, Y. Fitz, R. Correa-Araujo, C. Natanson, R. L. Danner, S. M. Banks, and P. Q. Eichacker
Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model
J Appl Physiol, June 1, 2005; 98(6): 2155 - 2162.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. F. Benjamim, S. K. Lundy, N. W. Lukacs, C. M. Hogaboam, and S. L. Kunkel
Reversal of long-term sepsis-induced immunosuppression by dendritic cells
Blood, May 1, 2005; 105(9): 3588 - 3595.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Leukocyte Biology.